Effect of DMARDs on the immunogenicity of vaccines

Y van Sleen, KSM van der Geest… - Nature Reviews …, 2023 - nature.com
Vaccines are important for protecting individuals at increased risk of severe infections,
including patients undergoing DMARD therapy. However, DMARD therapy can also …

Emerging advances in fluorescence imaging and phototherapy of arthritis

X Wang, J Dai, C Shao, T Goto… - Interdisciplinary …, 2023 - Wiley Online Library
Arthritis is a chronic disease whose etiology is difficult to pinpoint, and the difficulty of arthritis
detection and subsequent treatment causes enormous distress to patients. In recent years …

2023 American College of Rheumatology (ACR)/American College of Chest Physicians (CHEST) guideline for the treatment of interstitial lung disease in people with …

SR Johnson, EJ Bernstein, MB Bolster… - Arthritis Care & …, 2024 - Wiley Online Library
Objective We provide evidence-based recommendations regarding the treatment of
interstitial lung disease (ILD) in adults with systemic autoimmune rheumatic diseases …

The outcomes of children born to mothers with autoimmune rheumatic diseases

L Andreoli, J Andersen, T Avcin… - The Lancet …, 2024 - thelancet.com
Maternal autoimmune rheumatic diseases can influence the outcomes of children through
several life stages. During pregnancy, maternal inflammation and autoantibodies can hinder …

[HTML][HTML] Vaccination in the Era of Immunosuppression

F Alnaimat, JJG Sweis, J Jansz, Z Modi, S Prasad… - Vaccines, 2023 - mdpi.com
Patients with autoimmune inflammatory rheumatic diseases (AIIRDs) are at increased risk
for severe infections. Vaccine responses and safety profiles may differ between AIIRD …

The time of equipoise on the use of biological DMARDs in for inflammatory arthritis during pregnancy is finally over: a reappraisal of evidence to optimise pregnancy …

I Giles, I Thorne, NS Schmidt, C Reid… - The Lancet …, 2024 - thelancet.com
Active inflammatory arthritis in pregnancy is associated with an increased risk of adverse
pregnancy outcomes. Treatment of active inflammation and maintenance of low disease …

[HTML][HTML] Immunogenicity and safety of adjuvanted recombinant zoster vaccine in rheumatoid arthritis patients on anti-cellular biologic agents or JAK Inhibitors: a …

V Venerito, P Stefanizzi, L Cantarini, M Lavista… - International Journal of …, 2023 - mdpi.com
Rheumatoid arthritis (RA) patients on JAK inhibitors (JAKi) have an increased HZ risk
compared to those on biologic DMARDs (bDMARDs). Recently, the Adjuvanted …

[HTML][HTML] Adalimumab

CR Ellis, CE Azmat - 2020 - europepmc.org
Adalimumab - Abstract - Europe PMC Sign in | Create an account https://orcid.org Europe PMC
Menu About Tools Developers Help Contact us Helpdesk Feedback Twitter Blog Tech blog …

Vaccination updates and special considerations for systemic lupus erythematosus patients

J Law, C Sorrento, A Saxena - Current Opinion in Rheumatology, 2024 - journals.lww.com
Vaccination updates and special considerations for systemic... : Current Opinion in
Rheumatology Vaccination updates and special considerations for systemic lupus erythematosus …

Should we vaccinate during an active rheumatic disease?

M Bijl, J Westra, S Mancuso, P Bearzi, R Giacomelli… - Autoimmunity …, 2023 - Elsevier
Timing of vaccination and its relationship with concomitant immunosuppressive therapy has
been a matter of debate in the field of AutoImmune Inflammatory Rheumatic Diseases …